These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1710293
21. Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells. Dubreuil M, Sportza L, D'Addario M, Lacoste J, Rooke R, Wainberg MA, Hiscott J. Virology; 1990 Nov; 179(1):388-94. PubMed ID: 1699354 [Abstract] [Full Text] [Related]
22. Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha. Macé K, Duc Dodon M, Gazzolo L. Virology; 1989 Feb; 168(2):399-405. PubMed ID: 2492697 [Abstract] [Full Text] [Related]
28. Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1. Hamamoto Y, Takamatsu K, Kobayashi S, Yamaguchi K, Yamamoto N, Kobayashi N. Virus Genes; 1989 Nov; 3(2):141-52. PubMed ID: 2559541 [Abstract] [Full Text] [Related]
29. A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. Weissman D, Poli G, Bousseau A, Fauci AS. Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2537-41. PubMed ID: 7681601 [Abstract] [Full Text] [Related]
30. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. Rieckmann P, Poli G, Kehrl JH, Fauci AS. J Exp Med; 1991 Jan 01; 173(1):1-5. PubMed ID: 1985116 [Abstract] [Full Text] [Related]
31. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Mol Med; 1995 Sep 01; 1(6):667-77. PubMed ID: 8529133 [Abstract] [Full Text] [Related]
34. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL. J Exp Med; 1991 Dec 01; 174(6):1593-600. PubMed ID: 1744586 [Abstract] [Full Text] [Related]
37. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus. Crowe SM, McGrath MS, Elbeik T, Kirihara J, Mills J. J Med Virol; 1989 Nov 01; 29(3):176-80. PubMed ID: 2533247 [Abstract] [Full Text] [Related]
38. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus. Simon G, Moog C, Obert G. Chem Biol Interact; 1994 Jun 01; 91(2-3):111-21. PubMed ID: 7514959 [Abstract] [Full Text] [Related]
39. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS. Proc Natl Acad Sci U S A; 1990 Jan 01; 87(2):782-5. PubMed ID: 2300561 [Abstract] [Full Text] [Related]